Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: vorinostat|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)